PTGS2 and Alzheimer disease: Neferine and betalin inhibit Aβ-induced inflammation by reducing TNF-α, IL-1β, IL-6, iNOS, COX-2, and NF-κB expression in the hippocampus at 4 and 28 days after AlCl3-induced AD, respectively [48,58].